TDTapan Kanti Das
Tapan Kanti Das
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tapan Kanti Das has a total of 262 co-authors. Here are the top co-authors by number of shared publications:
Denis L. Rousseau
Albert Einstein College of Medicine, Department of Physiology and Biophysics, Bronx, NY 10461
18 shared publicationsLi Tao
A Molecular & Analytical Development , Bristol-Myers Squibb , New Jersey , USA
7 shared publicationsShyamalava Mazumdar
6 shared publications- Danny K. Chou
Compassion BioSolution, LLC, Lomita, CA 90717, USA
5 shared publications Joel M. Friedman
5 shared publications- Manon Couture
Université Laval
5 shared publications
Latest Publications
- 9 October 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (2) , 377-385
Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation Strategies
- 9 October 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (2) , 377-385
Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation Strategies
- 1 April 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (4) , 919-932
Emerging Challenges and Innovations in Surfactant-mediated Stabilization of Biologic Formulations
- 1 April 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (4) , 919-932
Emerging Challenges and Innovations in Surfactant-mediated Stabilization of Biologic Formulations
- 1 April 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (4) , 868-886
Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality
- 1 April 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (4) , 868-886
Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality
- 1 March 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (3) , 699-709
An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle Dispersion
- 1 March 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (3) , 699-709
An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle Dispersion
- 31 January 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (4) , 951-959
Nucleation in Protein Aggregation in Biotherapeutic Development: A look into the Heart of the Event
- 31 January 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (4) , 951-959
Nucleation in Protein Aggregation in Biotherapeutic Development: A look into the Heart of the Event
- 15 December 2021
- Published by Elsevier in Journal of Pharmaceutical Sciences
A Cluster of Articles in Memory of Wim Jiskoot, Ph.D.
- 15 December 2021
- Published by Elsevier in Journal of Pharmaceutical Sciences
A Cluster of Articles in Memory of Wim Jiskoot, Ph.D.
- 1 February 2021
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 110 (2) , 935-945
A Detailed Protocol for Generation of Therapeutic Antibodies with Galactosylated Glycovariants at Laboratory Scale Using In-Vitro Glycoengineering Technology
- 1 February 2021
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 110 (2) , 935-945
A Detailed Protocol for Generation of Therapeutic Antibodies with Galactosylated Glycovariants at Laboratory Scale Using In-Vitro Glycoengineering Technology
- 1 January 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (1) , 116-133
Stress Factors in mAb Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and Control Strategy
- 1 January 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (1) , 116-133
Stress Factors in mAb Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and Control Strategy